Sunday, September 27, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $341.07 +1.53%
MSFT $516.17 +3.66%
GOOGL $343.92 +0.46%
AMZN $249.67 +0.12%
TSLA $372.11 -1.54%
META $751.66 -3.33%
NVDA $225.07 +0.22%
JPM $343.06 +1.33%
BTC $37.16 -0.40%
ETH $25.72 -0.08%
Latest Signing ceremony for contribution agreements between WHO and France Oct 17, 2024
AAPL
$341.07
▲ 1.53%
MSFT
$516.17
▲ 3.66%
GOOGL
$343.92
▲ 0.46%
AMZN
$249.67
▲ 0.12%
TSLA
$372.11
▼ 1.54%
META
$751.66
▼ 3.33%
NVDA
$225.07
▲ 0.22%
JPM
$343.06
▲ 1.33%

Top Stories

Markets →
All Markets Technology Economy Science Health Sports Entertainment Politics
Science Daily
Scientists find a new weakness in treatment-resistant prostate cancer
Researchers have found a potential way to attack prostate cancers that evade treatment by changing their cellular identity. Combining two types of drugs reversed many of these changes and sharply slowed tumor growth in preclinical experiments, offering a possible new strategy for aggressive, treatment-resistant disease.
science  Sep 8, 2026
Bloomberg Markets
Stock Resiliency Depends on Moves by the Fed, Says Principal’s Shah
“The next couple of months are likely to be pretty rocky with only modest gains to be had for the rest of the year,” says Seema Shah, chief global strategist at Principal Asset Management. Shah says a possible series of hikes by the Federal Reserve can provide some resistance for equities. (Source: Bloomberg)
business  Sep 8, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free